Metformin versus metformin plus pioglitazone on gonadal and metabolic profiles in normal-weight women with polycystic ovary syndrome: a single-center, open-labeled prospective randomized controlled trial.

J Ovarian Res · 2024 · PMC10875752 · PMID 38374053

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

In addition, AUCGlu, AUCIns, and AUCIns/AUCGlu did not improve in either group after the 12-week treatment ( P > 0.05); however, they showed a decreasing trend in the PIOMET group (Fig. 2 (A) and (B) and Table 2 ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.